Next Article in Journal
Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice
Previous Article in Journal
The Multifaceted Interactions of Dictyostelium Atg1 with Mitochondrial Function, Endocytosis, Growth, and Development
Previous Article in Special Issue
Understanding Developmental Cell Death Using Drosophila as a Model System
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research

Department of Biology, Indiana University, Bloomington, IN 47401, USA
Cells 2024, 13(14), 1192; https://doi.org/10.3390/cells13141192
Submission received: 30 April 2024 / Revised: 2 July 2024 / Accepted: 12 July 2024 / Published: 14 July 2024
(This article belongs to the Special Issue Drosophila Models in Autophagy and Aging)

Abstract

:
Studies on numerous species have demonstrated strikingly conserved mechanisms that determine the aging process, from yeasts to worms, flies, zebrafish, mice, and humans. The fruit fly Drosophila melanogaster is an excellent model organism for studying the biological basis of normal aging and etiology of age-related diseases. Since its inception in 1967, the Bloomington Drosophila Stock Center (BDSC) has grown into the largest collection of documented D. melanogaster strains (currently > 91,000). This paper aims to briefly review conserved mechanisms of aging and provides a guide to help users understand the organization of stock listings on the BDSC website and familiarize themselves with the search functions on BDSC and FlyBase, with an emphasis on using genes in conserved pathways as examples to find stocks for aging studies.

1. Introduction

An almost universal phenomenon of life from unicellular organisms to humans is the gradual decline of functions over time, broadly termed aging [1,2]. Cellular senescence is a normal part of aging; however, it is not synonymous with organismal aging in higher-order animals, where organ physiology, crosstalk among tissues [3,4], and host–commensal interactions all play a pivotal role [5,6] in the course of deterioration of physical and physiological functions, along with increased risk of morbidity and mortality. It is a manifestation of complex time-dependent changes at the molecular and cellular levels under variable environments. While chronological age is a commonly used measurement and predictor of age-related functions, the rate of biological aging varies widely among species and within populations [7]. An emerging trend in aging research has highlighted the importance of healthy aging beyond lifespan extension [8]. With the global population aging projected to put an ever-increasing amount of social and economic burden on all countries, extending fitness and function has become the research focus of academic scientists and an investment area for large pharmaceuticals and technology corporations.

2. Conserved Molecular Mechanisms Involved in Aging

2.1. The Insulin/Insulin-Like Growth Factor Signaling and mTOR Pathway

Studies from a wide range of species have demonstrated strikingly conserved mechanisms that determine the lifespan and rate of aging from yeasts to the nematode worms, fruit flies, zebrafish, mice, and humans [9,10]. Among them are the insulin/insulin-like growth factor-1 signaling (IIS) and the mechanistic target of rapamycin (mTOR) pathways [11]. These ancient signaling cascades are the main regulators of metabolism and growth. However, a myriad of molecular pathways and biological processes downstream of IIS and TOR are involved in lifespan determination [12,13]. Disruptions of genes encoding positive regulators of IIS and mTOR signaling extend the lifespan. For example, mutations of the insulin receptor daf-2 almost doubled the lifespan in worms [14], loss of function of insulin receptor (InR) and insulin receptor substrate (IRS) extended the lifespan in Drosophila [12,15,16], and attenuations of InR or insulin-like growth factor 1 (IGF-1) signaling improved longevity in mammals in a tissue and sex-dependent manner [17]. Consistently, loss of the negative regulator FOXO downstream of IIS abolished the effect of IIS mutations on lifespan, whereas overexpression of FOXO delayed aging [18,19,20,21,22]. Furthermore, mounting evidence supports findings from genetic studies: from worms to flies and mammals, caloric restrictions and drugs that target the IIS/mTOR, namely, metformin and rapamycin, extended the lifespan and improved health and age-associated functional decline [23,24,25,26,27,28,29,30,31]. Numerous genes involved in stress responses, cell proliferation, metabolism, and longevity interact with each other, and many of them converge on the IIS/mTOR signaling pathways; reduction in IIS/mTOR activities is associated with fitness and cancer resistance [32,33,34]. Interestingly, analysis of genes involved in the mTOR signaling network from 48 mammalian species also revealed evolutionary features that are unique to long-lived species [31].
mTOR is not only an important regulator of protein metabolism, but it also plays a critical role in autophagy [35]. As a normal part of physiological activities, damaged cellular materials are cleared by the ubiquitin-proteasome and autophagy [36]. During aging, this mechanism is impaired, resulting in a loss of proteostasis that is often associated with neurodegenerative diseases [36,37]. Thus, enhanced autophagy activities have been proposed to have beneficial health effects. Indeed, inhibition of mTOR activates autophagy and improves cellular function and extends lifespan [38]. In support of the central role of autophagy in aging, some diet interventions that enhance longevity require intact autophagy functions [35,39].

2.2. Mitochondrial Dysfunction

Reactive oxygen species (ROS) are natural byproducts of the oxidative phosphorylation that generates ATP in the mitochondria. Low levels of ROS are important for normal cellular functions, but dysregulated release of ROS causes damage to proteins and cellular compartments [40], including mitochondria. During aging, a decline of the antioxidant system and deterioration of mitochondrial quality control mechanisms such as selective autophagy of mitochondria (mitophagy), further increase oxidative stress, inflammation, and age-dependent diseases [41,42,43,44].
Mitochondrial dysfunction is frequently associated with age-dependent metabolic disorders and neurodegenerative diseases [45]. Interestingly, dietary restriction extends lifespan at least partially through activation of the AMP-activated protein kinase (AMPK), which in turn inhibits mTOR activity, promotes mitophagy and improves mitochondrial homeostasis [46,47,48]. Recent studies found that natural compounds such as coumarin and Urolithin A induce mitophagy and extend lifespan in worms [49,50]. Consistently, genetic studies of mitophagy-related genes in model organisms have demonstrated that overexpression of genes that promote mitophagy extends longevity, whereas their loss reduces the lifespan [51].

2.3. Inflammation

Innate immunity is the oldest and most conserved aspect of immunity against pathogens in the animal kingdom [52,53]. This acute protective mechanism deteriorates during aging [54], along with more immune cells exiting the cell cycle entering a senescent state known as immunosenescence [12,55]. This weakened immune capacity increases the risk of infection and mortality.
On the other hand, chronic elevation of inflammatory levels without external pathogens is a hallmark of aging [56]. The prominent manifestation of inflammatory status in a myriad of age-dependent diseases, including neurodegenerative diseases, cardio-vascular diseases, metabolic disorders, and autoimmune diseases, has popularized the term “inflammaging” [56,57], which posits that cellular stress is the common trigger of inflammation, and macrophages are central players in the inflammatory events.

2.4. Microbiome

The impact of microbiomes, especially the intestinal microbiome, on host physiology, behavior, and “healthspan” (loosely defined as “the period of life spent in good health, free from the chronic diseases and disabilities of aging” [58]) has been well documented [59,60,61,62]. Drosophila is an emerging model to study the intersections of diet intervention, microbiota, innate immunity, and aging [12,63]. In addition, gut metabolites play an important role in mediating the anti-aging effect of flavonoids [64].

2.5. Circadian Rhythms

One prime example of organism–environmental interactions is the alignment of the daily activities and biological functions with the day:night cycle on earth. The intrinsic circadian clocks orchestrate rhythmic metabolic and physiological processes in virtually all organisms from unicellular cyanobacteria to humans [65]. Disruption of circadian clocks is associated with countless age-dependent diseases, and targeting the circadian clock to extend healthspan has become a new direction in medicine [66,67]. Interestingly, dietary restrictions and the timing of feeding affects the healthspan via the circadian clock [68,69,70,71,72], which is weakened during aging in many organisms [73,74,75]. Autophagy is also intertwined with circadian clocks and sleep [76,77,78,79,80,81,82].

3. Age-Associated Diseases and Drug Discovery

Human aging is a systemic decline of physical and physiological functions along with increased risk of diseases, including metabolic syndromes, cardio-vascular diseases, musculoskeletal disease, cancer, immune disorders, neurodegeneration, and cognitive deficits. Injuries from falls, largely due to deterioration of neuro-muscular functions in fine motor control, gait, and balance at old age are among the leading causes of death [83]. With the global population aging, age-related diseases pose an ever-increasing health, social, and economic burden on all countries [84]. To fight Alzheimer’s disease (AD) alone, the United States has implemented a national plan as required by congressional legislation in 2011, with ambitious goals to treat and prevent Alzheimer’s and related dementias. However, two decades of clinical trials of AD drugs have been largely unsuccessful, underscoring the complex etiology of the disease [85].
While aging as we currently understand it is irreversible, the rate of aging varies widely among species. It is conceivable and even feasible to slow down biological aging processes [86]. Towards this end, animal models have been used to screen for compounds that extend the lifespan [87]. Pharmaceutical corporations and venture capitals have invested heavily in projects targeting hallmarks of aging and to extend the lifespan [88,89,90], and some promising drug candidates are already in clinical trials.

4. Drosophila as a Model Organism for Aging Studies

Not surprisingly, genetically tractable organisms such as the baker’s yeast Saccharomyces cerevisiae, nematode worm Caenorhabditis elegans and fruit fly Drosophila melanogaster (hereafter ‘Drosophila’) are popular models of choice for aging studies. Environmental factors aside, genetics is the most significant factor that determines the aging process. Importantly, about 60% of the Drosophila genes have human homologs [91]. Drosophila has complex cellular signaling networks and equivalent organs like those in mammals, a rich repertoire of biological and molecular processes, sophisticated behaviors, and a short reproduction cycle, making it an ideal model to study the mechanism of normal aging and pathological underpinnings of age-related diseases. A large collection of mutants of candidate genes is readily available for drug discovery [92,93,94,95,96,97], validation, and repurposing of FDA-approved compounds for aging studies [29,38].
Since the early 20th century, Drosophila genetics has progressed from discoveries of spontaneous mutant alleles to genome-wide, large-scale generation of allelic mutations, transgenes, and tools for numerous applications for investigations of molecular and cellular processes, development, physiology, neurobiology, behavior, and aging. The rapid expansion of genetic strains necessitates a central repository to maintain the stocks and distribute them to the worldwide research community. Since its inception in 1967, the Bloomington Drosophila Stock Center (BDSC) has grown into the largest collection of live D. melanogaster strains with unique genetic compositions (currently >91,000), all of which can be found on the BDSC website listings with stocks by experimental use or feature (category), or by using search functions to locate stocks based on symbols for gene, allele, component, genotype, chromosome, donor, and stock comments. The main goal of this paper is to help users navigate the BDSC website and FlyBase pathway search function to find strains of interest to their studies, with the understanding that genes and pathways involved in aging are selected for the purpose of illustration and discussion.

5. Navigating the BDSC Website

5.1. The Overall Organization of the BDSC Website

The BDSC website (https://bdsc.indiana.edu/) (accessed on 11 July 2024) is designed to make it informative but also easy to navigate. The top ribbon panel of the BDSC website homepage (Figure 1) has six navigation tabs, three of which have a dropdown menu. All website contents can be accessed via this navigation panel. The middle panel consists of two sections: “Stock Search” and “Browse Stocks”, with the latter largely organized by the main components of the stocks: deficiencies, GAL4, lexA, insertions, fluorescent proteins, wild-type etc., along with categories based on stock utilities such as mapping, clonal analysis, genome editing, and so on. The purpose of this layout is to provide quick access to major subcollections without overcrowding the homepage.
The lower panel consists of three large buttons for easy access to relevant information pages and an Order Form, whether you are new to the BDSC website or have a list of stocks ready to order.

5.2. Browsing Tables

When a new stock arrives, BDSC scientists formalize the genetic component symbols and associate various properties in a custom relational database. This strict protocol makes it possible to write queries based on component and stock properties to automatically populate a large number of browsing tables. There are two main entrances to tables with pre-compiled stocks listing genotypes, main components, use comments, and chromosomes. The large subcollections are listed on the homepage (https://bdsc.indiana.edu/) (accessed on 11 July 2024). For example, clicking on the GAL4/GAL80 link on the homepage will open the index page (https://bdsc.indiana.edu/stocks/gal4/index.html) (accessed on 11 July 2024) for all GAL4 and GAL80 stocks. The GAL4/UAS binary system collections are useful for studying the effects of a specific tissue or cell type on lifespan, or the interaction between tissues and cells. About half of the GAL4 transgenes (>8700) carry the intact GAL4 transcription activator that can directly drive the expression of UAS-transgenes. The other half (~7800) carry the split hemi drivers with the GAL4 DNA binding domain or the p65 (or VP16) activation domain, which when combined in the same stock expresses a functional GAL4 driver in the intersection of both hemi-drivers (via leucine zipper pairing). These split hemi-drivers are great for ‘mix-and-match’ studies to explore new expression patterns. In addition, BDSC maintains a set of split combo stocks with a stable combination of transgenes carrying DNA binding domain and activation domain (~3500) donated by the Janelia FlyLight Project (https://www.janelia.org/project-team/flylight) (accessed on 11 July 2024).
The split-combo webpage can be found on the GAL4 index page (https://bdsc.indiana.edu/stocks/gal4/index.html) (accessed on 11 July 2024). From there, clicking on the split-GAL4 link will open the information page (https://bdsc.indiana.edu/stocks/gal4/split_intro.html) (accessed on 11 July 2024) for all split-hemi, split-combo stocks. On this page, clicking on the split-combo link leads to the split-combo table (https://bdsc.indiana.edu/stocks/gal4/splitcombo_all.html) (accessed on 11 July 2024). Users can filter the column headers using various criteria. Clicking on a link in the table column (Janelia line) will open the image page on the FlyLight website, which details expression patterns in the central nervous system (e.g., https://splitgal4.janelia.org/cgi-bin/view_splitgal4_imagery.cgi?line=SS51118) (accessed on 11 July 2024). Most users search for Janelia line ID based on publications describing its expression pattern (see the FlyLight webpage for details: https://splitgal4.janelia.org/cgi-bin/splitgal4.cgi) (accessed on 11 July 2024).
In an effort to expand the use of the large collection of GAL4 (split-hemi) drivers, BDSC has screened 7300 split-GAL4 lines and characterized the expression pattens of the hemi drivers in the adult intestine (https://bdsc.indiana.edu/stocks/gal4/midgut_splitgal4.html) (accessed on 11 July 2024), which plays an important role in regulating innate immune and inflammatory responses, host–microbiota communication, and aging [98].
Another large collection at BDSC includes the transgenic RNAi stocks generated by the Transgenic RNAi Project (TRiP) [99]. All target genes are listed on this page (https://bdsc.indiana.edu/stocks/rnai/rnai_all.html) (accessed on 11 July 2024), so it is easy to use a filter on the gene column. TRiP is actively developing sgRNA transgenes for gene knockout and gene overexpression. BDSC maintains > 3200 sgRNA transgenes for knockout, and >1800 sgRNA transgenes for target gene expression. The guide RNA webpage (https://bdsc.indiana.edu/stocks/genome_editing/sgrna.html) (accessed on 11 July 2024) provides relevant transgene and vector information and links to the Harvard TRiP project website (https://fgr.hms.harvard.edu/fly-in-vivo-rnai) (accessed on 11 July 2024).
The advent of novel fluorescent probes has greatly expanded the collection of fluorescent transgenes (https://bdsc.indiana.edu/stocks/gfp/index.html) (accessed on 11 July 2024). BDSC has a rich collection of fluorescent reporters that change color or intensity depending on cellular physiological processes, such as changes in cellular pH, calcium dynamics, redox status, membrane potential, ER stress, synaptic connections, and so on. These reporters can be used to investigate age-dependent alterations at the cellular level. This table can be accessed via the homepage: clicking on “Fluors” opens the fluorescent protein index page (https://bdsc.indiana.edu/stocks/gfp/index.html) (accessed on 11 July 2024); from there, clicking on the “Markers, regulator, reporters…” link under the “Fluor-tagged proteins” section opens the fluorescent reporters page (https://bdsc.indiana.edu/stocks/gfp/gfp_mark.html) (accessed on 11 July 2024). Non-fluorescent markers and reporters can be found on the stock index page (https://bdsc.indiana.edu/stocks/index.html) (accessed on 11 July 2024).
The second way to access the tables of precompiled stocks is the “STOCKS” tab in the top navigation panel (https://bdsc.indiana.edu/stocks/index.html) (accessed on 11 July 2024), which presents most stock categories in an expandable tabular list.

5.3. Searches

To better utilize the search tools on the BDSC website, it is important to know how genetic information is curated at BDSC. A stock genotype is comprised of text strings called components, i.e., alleles, insertions, balancers, and so on. For each component, the associated genes and nature of the allele, tag, descriptive comment such as gene expression, genomic location (map), feature or use of the component, and the original publication that characterizes the component are parsed into various database tables. Donor, publication (if multiple components of a specific stock are used for a particular experiment), descriptive comments about the purpose or use, and synonyms of the stock are associated with the stock number in the BDSC database. Note that visible markers are added to the genotype for transgenes (the text string in the genotype between “{“ and “=”, e.g., PBac{y[+mDint2] w[+mC]=UAS-hAKT1.HA}VK00037), but not associated with components in the database. These relational associations form the basis of the search functions described in the sections below.

5.3.1. Stock Search

The Stock Search interface can be accessed at https://bdsc.indiana.edu/Home/Search (accessed on 11 July 2024), from the homepage (https://bdsc.indiana.edu/) (accessed on 11 July 2024), or from a link on the other two search pages. This is a quick search using simple terms in a single search box to fetch stock data that match any of the following terms:
- stock number
- gene symbol (note that BDSC uses FlyBase [100] symbols for genes)
- component symbols
- text string of gene symbol, component symbol, genotypes, stock comments, donor names.
Note that a wildcard Boolean (*) is added to both ends of the search term, and if multiple terms (separated by space) are entered, an “AND” operator is automatically used in the query, and the order of terms is ignored. This Stock Search often retrieves a long list of stocks. While it takes effort to wade through the list, a desirable set of stocks can be obtained by checking the results and refining the terms in a few trials. It also has the added benefit of finding related stocks of which users may be unaware.
If a single stock number is entered into the Stock Search box, it automatically retrieves that stock, instead of searching the whole database for text strings containing that number. A combination of numbers separated by a space will be treated as combination of text strings. Likewise, a combination of a number and a text string (separated by space) will be treated as text strings with an “AND” operator. It will search gene symbols, component symbols, genotypes, comments, and donor names, but not stock numbers.
Because the Stock Search uses text strings to search many text fields in the database, the query is designed to ignore certain invalid inputs. For example, if only a single letter is entered into the Stock Search box, such as N (gene symbol for Notch), p (gene symbol for pink), it is automatically rejected because numerous records contain such single letters. Likewise, entering an invalid term (e.g., a random text string) that is not contained in the database will return no record, but if it is combined with another text string that is contained in the database, the results of the valid search term are returned while the invalid term is ignored (otherwise, the invalid search term will nullify the valid query).
In addition, Greek symbols need to be spelled out in the Stock Search term: i.e., type “betaTub85D”, instead of “βTub85D”; “Delta1” instead of “Δ1”. It is worth noting that FlyBase has changed the gene symbol for Dl to “Delta” to avoid confusion with the gene symbol for dorsal (dl). Thus the search term “Delta” brings out alleles and transgenes for the gene Delta, but it also fetches other records with the text string Delta/delta in gene symbols such as deltaTry (δTry), allele and transgene symbols GLaz[Delta2], P{UAS-Psn.527.deltaE9}2, and so on.

5.3.2. Advanced Stock Search

While the Stock Search described above can take multiple search terms, they are not defined to specific fields in the database. The Advanced Stock Search (Figure 2) is designed specifically for stocks (genotype, donor, stock comment, chromosomes affected), but not for components. It can be accessed at https://bdsc.indiana.edu/Home/AdvancedSearch (accessed on 11 July 2024), from the homepage (https://bdsc.indiana.edu/) (accessed on 11 July 2024), or from a link on the other two search pages. Users can add three search terms (text strings) for genotypes. The toggle “any/all” at the top can be used to include or exclude stocks in the hit list. Furthermore, text strings from the stock comments or donor names can be used either alone or in combination with genotype terms. It is good practice to use “any” and “contain” to retrieve a more inclusive list first, then use a combination of restrictions to narrow down the list. This search function is particularly useful for finding stocks with combinations of components on specified chromosomes. Many users also find it convenient to use the donor’s name to find all stocks from that donor.

5.3.3. Advanced Symbol Search

This search function is best suited to find a component with specific features (such as gene trap, noncoding RNA etc.) (Figure 3). It can be accessed at https://bdsc.indiana.edu/Home/AdvancedComponentSearch (accessed on 11 July 2024), from the homepage, or via a link at the bottom of the other two search pages. Here the “symbol” refers to a stock component, i.e., parts of a genotype that comply with the FlyBase nomenclature, for example, InR[E19] (allele), PBac{UAS-hAKT1.HA}VK00037 (transgenic insertion), Df(2R)Atg7[d77] (deficiency), and CyO (balancer). Because visible markers for transgenes are only added to genotypes, they should be excluded in the component symbol search.
Because all components are associated with gene information such as the nature of the allele/insertion, users can easily narrow the hit list to a specific type of allele/insertion for the gene of interest, by selecting the dropdown menu (the default is “all categories”; see Table 1 for explanations). Switching the toggle at the top (“any/all”) changes the dropdown menu for genes and symbols, so different set of terms can be used to either expand or narrow the search further. In addition, the lower panel can be used together with the upper panel or alone to search text strings in symbols or comments. For insertions, users can specify which chromosome is affected.
Unlike that of the Stock Search and Advanced Stock Search, the search results of the Advanced Symbol Search are components that can be selected to retrieve stocks that carry them.

5.4. Useful Tips for Searches

a. All search items are treated as case-insensitive.
b. FlyBase symbols are used in the BDSC database and on the website. For example, the microtubule-associated protein tau, implicated in Alzheimer’s disease, has the Human Genome Organization Gene Nomenclature Committee (HGNC) gene symbol ‘MAPT’. BDSC follows FlyBase nomenclature of non-melanogaster gene with the four-letter prefix of the genus\species abbreviation: Hsap\MAPT. Because it is commonly known as “tau” in the literature, BDSC adds the common name to MAPT in the comment field (e.g., expresses human MAPT (tau) under the control of UAS) to help users find all transgenes carrying MAPT, either using the search term ‘MAPT’ or ‘tau’.
c. Stock comments and component comments are usually different. In most cases, information related to the use of the strain and notes on balancers and markers are attached to a stock, while descriptive comments related to the nature of the construct and allele are associated with individual components of a genotype. In Stock Search, both comment fields are used, whereas the Advanced Stock Search and Advanced Symbol Search use their specific comment fields.
d. For users unfamiliar with Drosophila nomenclature, these interspecies mining tools are very useful to find fly ortholog/paralogs: Gene2Function [101] (https://www.gene2function.org/search/web/) (accessed on 11 July 2024) and BioLitMine [102] (https://www.flyrnai.org/tools/biolitmine/web/) (accessed on 11 July 2024).

5.5. Sharing Information between BDSC and FlyBase

To understand the smooth transition between BDSC and FlyBase websites, it will help to know how stock data are processed into the BDSC database and how such data are validated against FlyBase, a comprehensive database of genetic and molecular data for D. melanogaster and other Drosophila species [100,103]. Donor-provided genotypes and publications will be first checked to see if FlyBase has curated symbols from that reference, including transgenic insertions, alleles, aberrations (duplication, deficiency, inversion). For components that already have FlyBase curations, BDSC adds the corresponding FlyBase ID (FBid) for genes and components, so they are linked to FlyBase when the new stocks are published on the BDSC website. If the donor-provided reference has not been curated by FlyBase, BDSC will ask FlyBase to curate the paper; if the components have not been published, BDSC will send personal communications to FlyBase with additional donor-provided information such as the nature of the allele, transgene generation, expression, and chromosomal location. These new components usually get their corresponding FlyBase ID at the next public release of FlyBase webpages.
BDSC also updates FlyBase with new stock information in every release cycle. At the same time, genotypes of all stocks are parsed into individual components to compare with FlyBase symbols, and the ones without matching FlyBase records are updated in the BDSC database. All known components are associated with alleles and genes in the FlyBase database, and their corresponding FlyBase IDs are checked against the BDSC database and the missing IDs are backloaded. Thanks to this tight association of BDSC stock components with the FlyBase database, clicking on the component on the BDSC stock page will open a FlyBase report page with detailed information about the component; users can also take advantage of the vast curation information on FlyBase [100,103] to find stocks. Figure 4 provides a simple decision flow on when to use BDSC or FlyBase for relevant information. As discussed in multiple sections below, a list of genes retrieved through a FlyBase Pathways search can be easily converted into symbols, which then can be converted to stocks with a button click.

5.6. Ordering Stocks

Stocks found through the Stock Search or Advanced Stock Search can be easily added to the Cart by clicking on the “Add to Cart” button next to the genotype in the search results. Components found through the Advanced Symbol Search need to be selected (using a check box next to the symbol), before clicking on the “Find Stock” button at the bottom of the search results page. If a user already has a list of stock numbers from other sources, use the “Order Form” on the BDSC homepage. The checkout process is similar to many e-Commerce websites that require account information and agreement to terms of stock use. It should be noted that stocks added to the Cart when a user is not logged in will be lost by clearing the browser data (in local storage); stocks added to the cart while logged in are not affected (i.e., these data are stored on the web server).

6. Finding Stocks for Studying Conserved Mechanisms

6.1. IIS and mTOR

The IIS and mTOR signaling pathways have been extensively studied, so finding stocks for these well-known genes is easy with the Advanced Symbol Search. Nonetheless, it is difficult to devise a search model that fits all needs. For example, the gene symbol “Tor” has been used by the Drosophila community for a long time before its recent change to “mTor” to better distinguish it from the “tor” (gene symbol for torso). There are 42 gene symbols containing the text string “tor” in the BDSC database so it is not a good term to search. “mTor” is contained in eight gene symbols (including Lamtor, Samtor). Thus, using the “exactly matching” term “mTor” is the best way to obtain a clean list (22 symbols currently). Note that the numbers given in this paper are for illustration purposes. They may change over time due to stock additions/losses or gene symbol changes.
To find a comprehensive list of genes in the IIS and mTOR signaling pathways, users are encouraged to use a Pathways search on FlyBase: for example, the hit list for insulin signaling (77 genes) (FB2024_03, released on 25 June 2024) can be converted to 1085 BDSC stocks (Figure 5). Clicking on the “Stock Center…” link will open the stock report page on the BDSC website. The hit list can also be exported, and stock numbers can be uploaded to the Order Form on the BDSC homepage. Further mining of the gene group [100] data (e.g., Insulin-like Receptor Signaling Pathway https://flybase.org/reports/FBgg0000910) (accessed on 11 July 2024) helps narrow down the list to those core components, negative and positive regulators, and those with physical interactions.

6.2. Autophagy

The effect of the nutrient-sensing pathway on aging is in part mediated by autophagy. Many autophagy-related genes (ATGs) are highly conserved from yeasts to mammals [104]. Genetic studies further demonstrate the role of autophagy in aging: Atg7 mutant flies are hypersensitive to nutrients and are short-lived [105]. On the other hand, overexpression of Atg genes extends the lifespan [106,107,108]. A Stock Search of “autophagy” returns two stocks, both with a comment “autophagy marker” or “marker for autophagy” in the component comments. A Stock Search of “Atg” returns 279 stocks, including a lot of deficiencies that cover the Atg gene and non-relevant stocks with a comment on the translation start codon ATG, or a comment on fragment sequence such as CATGATGAAATAACA.
The Advanced Stock Search has limited use to retrieve all stocks related to Atg gene because many of them do not have the gene symbol in the genotype, e.g., the TRiP RNAi or gRNA stocks. In addition, a collection of the Rab GTPase transgenes that contains “Rab40-GAL4.ATG” are included in the results.
An Advanced Symbol Search for a gene that contains “Atg” returns 227 components, including deficiencies that cover the Atg gene region. After selecting the components by using the check box next to the component on the search results page, clicking on the “Find Stocks” button at the bottom of the page returns all relevant stocks. Excluding the deficiency returns 144 stocks. In comparison, a search of FlyBase data class “gene group” with “Autophagy” returns 20 autophagy-related genes (all symbols start with Atg). This hit list can be converted to stocks (225 stocks), which can be further filtered by the “Analyze” function to filter on “collection” (see the example in Figure 5): the Bloomington collection holds 135 stocks. These two lists have 134 stocks in common. Nine stocks are found only in the BDSC list; among them, two are GAL4 enhancer trap insertions between Atg1 and Sap130, five are transgenes carrying human ATG genes, and the remaining two are newly added stocks after the last FlyBase release. Because all gene symbols in the Autophagy gene group starts with “Atg”, users can refine the search as any component related to gene “starting with” “Atg”, which then excludes the five human Atg gene symbols starting with “Hsap\ATG”.
Mitophagy is a process that recycles damaged mitochondria by autophagy. The FlyBase gene ontology term “mitophagy” includes six genes (three overlap with autophagy-related genes and the other three genes involved in mitochondrial homeostasis). This hit list can be converted to 42 BDSC stocks (with 16 overlaps with the “autophagy” hit list).
The term “mitophagy” has been essentially dissociated with autophagy in the description of alleles and genetic tools. As such, a search of “mitophagy” on the BDSC website returns five stocks carrying transgenes expressing fluorescent proteins fused with the mitochondrial localization peptide, with a comment that they are used as “mitophagy reporters” (mito-QC, matrix-QC); none of them is present in the search results for “autophagy”. This example illustrates the value of curating the “use” information for genetic reagents. Indeed, a large number of BDSC webpages are organized into this type of “use” category. For example, the same five stocks can be found through browsing the fluorescent reporter page (https://bdsc.indiana.edu/stocks/gfp/gfp_mark.html) (accessed on 11 July 2024): filtering the “Reporter/marker” column in the table on this page with “mitophagy” will narrow down the list to five mitophagy reporter stocks.

6.3. Inflammation

Drosophila lacks adaptive immunity, but its innate immune system shares similarities with that of vertebrates [109] and it has become an excellent model to study host–pathogen interactions, innate immune memory, and inflammatory disease [110]. In addition to the recruitment of antimicrobial peptides to infection sites, IL-like receptor Toll and Nuclear factor-κB (NF-κB) cascades are activated to trigger an inflammatory response. NF-kB is a family of transcription factors (such as Dif, dl, Rel) involved in different processes of the immune and inflammatory responses. Interestingly, the IIS activity is correlated with NF-kB activity [111]. Constitutive activation of the NF-kB and Imd signaling pathways is associated with neurodegeneration and shortened lifespan in Drosophila and mice [56,111]; conversely, suppression of Toll/NF-kB or Imd signaling improves the lifespan [111,112,113]. These data suggest that NF-kB may serve as a therapeutic target to improve age-related diseases and extend the lifespan.
A Stock Search for “inflammation” on the BDSC website returns nothing, because this term is not contained in gene symbol, genotype, or stock comments. Similarly, searching “inflammation” on FlyBase returns 396 records in Disease Ontology but only six genes, which include the gene immune deficiency (imd). However, searching “immune” returns 851 alleles/insertions (associated with 1059 stocks, of which 725 are in BDSC); and 445 records in Gene Ontology; among them, “immune response” alone has 358 annotated genes (associated with 5280 stocks, including 2986 BDSC stocks). These large stock lists are comprehensive, but they are not helpful in picking specific stocks. Here the FlyBase curation of gene groups becomes handy. For example, within the Gene Ontology term “immune response”, there are 15 records in the gene groups, including the antimicrobial peptides group (99 stocks), Imd signaling pathway core components (339 stocks), positive (231 stocks) and negative (481 stocks) regulators of the Imd pathway, and so on. These smaller subsets make it easier for users to select specific stocks. Furthermore, most Drosophila researchers search stocks for their gene of interest, so the gene-centric curation provides sufficient information to find specific stocks. For example, searching the gene “imd” on FlyBase returns nine BDSC stocks, the same result as when using the Advanced Symbol Search on BDSC (excluding the Deficiency stocks).

6.4. Oxidative Stress

Excessive ROS in metabolically active cells such as neurons are implicated in age-dependent diseases like Alzheimer’s and Parkinson’s diseases. Genes encoding ROS scavenger proteins are well-studied in Drosophila, and gene symbols are unequivocal for these well-known enzymes; thus, a quick Stock Search for Sod, Cat, and Gst will return relevant stocks. To find regulatory genes important for oxidative stress responses, using the FlyBase gene ontology (GO) search for “oxidative stress” will pull out a comprehensive list of GO terms, such as “cellular response to oxidative stress” and “response to oxidative stress”. Annotated genes in each GO term can be converted to stocks as illustrated in Figure 5.

6.5. Microbiome and External Stressors

While a well-characterized wild-type strain is suitable to study the effect of microbiome composition on host physiology, the large collection of mutant strains at BDSC is a great resource for studies on gene–microbiota interaction and its impact on aging. Although large-scale applications for genome-wide screening of longevity mutants are not readily available for most laboratories, creative approaches have been used to speed up the identification of candidate genes. For example, unlike the traditional QTL mapping, extreme QTL mapping [114] can be employed for selection-based phenotyping of pools to recover mutants with extreme trait values, such as resistance to stressors and pathogens. Indeed, the Drosophila Synthetic Population Reference (DSPR) [115] panel has been successfully used to uncover the genomic loci associated with caffeine and xenobiotic resistance [116]. It is not unconceivable that many large collections of BDSC stocks can also be used to select extreme phenotypes under external stressors that are known to have strong impact on aging. Because most BDSC stocks have characterized sequence features, whole-genome sequencing of DNA pools of phenotyped individuals can help trace back to the genetic component responsible for the extreme phenotype. The readily available sequence information for the Drosophila melanogaster Genetic Reference Panel (DGRP) [117] and DSPR collections makes them extremely useful for quantitative genetic analysis of the effect of gene–microbiome interactions on healthspan. These two collections can be found via the “Wild-type” link on the BDSC home page.
To test the effect of gene expression in the midgut on aging, a set of 424 split GAL4 drivers [118] that are expressed in at least one of five major midgut regions can be used with the UAS-transgene of choice to express or knock down genes in specific cell types and midgut regions (https://bdsc.indiana.edu/stocks/gal4/midgut_celltypes.html) (accessed on 11 July 2024); among them, 88 split GAL4 drivers have limited expression in the enteroendocrine cells (https://bdsc.indiana.edu/stocks/gal4/midgut_EEs.html) (accessed on 11 July 2024).

6.6. Circadian Rhythms

BDSC has a collection of transgenes and mutants of circadian clock genes. One can use the combination of Stock Search and Advanced Symbol Search to find all stocks related to core circadian clock genes. For example, using “circadian” in a Stock Search returns 20 stocks, which include the ten stocks from the “rhythm” search. All of them have the text string “circadian” or “rhythm” in component or stock comments. A Stock Search for “clock” returns nothing, because “clock” is not in the gene symbol, genotypes, or comments.
Although there is currently no curation of circadian rhythms (clock) page on the BDSC website, FlyBase has a very nice Gene Ontology record for circadian rhythms (169 genes), which includes all 121 genes in the GO term “circadian behavior”. The hit list can be converted to 5389 stocks (3585 in the BDSC collection). This huge discrepancy between the BDSC search and FlyBase data mining is due to the fact that GO is a gene-centric curation of any genes reported to be involved in circadian rhythm regulation, and the conversion of the hit list to stocks is a query of the FlyBase database to fetch all stocks carrying any alleles of those genes; in contrast, BDSC component or stock comments are entered into the database when the stock is added to the collection, and usually it is prompted by donor-provided information (e.g., ‘this stock can be used for circadian rhythm experiments’). A good example is ebony (e): there are 1216 stocks on FlyBase (782 in the BDSC collection). Since the discovery of ebony mutations in 1923, ebony alleles had been extensively incorporated into stocks as morphological markers, before the role of ebony in circadian rhythms was reported [119]. Thus, data-mining results often need manual curation. For example, stock 1678 Ki[1] p[p] by[1] cu[1] red[1] e[1]/TM3, Sb[1] Ser[1] is clearly not a good pick as a circadian clock mutant strain, even though it has the e[1] allele.
The most effective way to retrieve these stocks is to use the “Advanced Symbol Search” on the BDSC website. It is recommended to use “exactly matching” gene symbols. One search of “per” or “tim” or “Clk” returns 93 stocks, another search of “cyc” or “Pdp1” or “vri” returns 99 stocks; and another search for “exactly matching” dco or starting with CkII or starting with Pdf returns 154 stocks. The same method can be applied to other genes involved in circadian rhythms: cwo, tws, cry, sgg, nmo, and so on.

7. Screening for Novel Mechanisms of Aging

As alluded to above, genome-wide screening for lifespan mutants is often cost-prohibitive and time-consuming. Nonetheless, one can take advantage of the large collection of stocks at BDSC for genetic screens of enhancer/suppressor- and tissue-specific effects on aging [120]. For example, a short-lived strain with X chromosome-linked alleles (or autosomal dominant alleles) can be combined with a suitable GAL4 to cross with a panel of UAS-RNAi lines and screen for lifespan extension. Extreme QTL mapping [114] can be applied to screen for natural variations that interact with known lifespan shortening alleles. BDSC has two complementary collections of wild-type strains with genome sequence data: DGRP and DSPR. The DGRP collection is wild-caught iso-female inbred lines from Raleigh, NC, USA. It has been used in >125 studies (see aggregated phenotype data at https://dgrpool.epfl.ch/) (accessed on 11 July 2024). The DSPR collection was established by interbreeding eight wild-type strains caught worldwide. Comprehensive information about these stocks and analytical tools are available at the DSPR website (https://wfitch.bio.uci.edu/~dspr/index.html) (accessed on 11 July 2024). In a similar vein, short-lived alleles can be used to screen for compounds that can reverse the deleterious effects of the known genetic mutation on lifespan.
During aging, the ability to climb decreases [121]. This simple negative geotaxis behavior can be used for genetic screens to identify super-climbers (those who maintain neuromuscular functions during aging). By using a semi-automated climbing assay for physical vigor and neuromuscular coordination, cross-sectional surveys can help identify candidate strains in a manageable time window.

8. Concluding Remarks

While the main focus of this paper is on aging, the genetic tools available for manipulating the Drosophila genome are among the most sophisticated in any multicellular organism, making it a versatile model organism to study fundamental biological mechanisms relevant to human health. As the largest Drosophila repository in the world, BDSC facilitates biomedical research by maintaining and distributing large collections of mutants and transgenic stocks, and by providing information and tools to identify stocks for specific projects. A synergistic collaboration between BDSC and FlyBase helps researchers find stocks and related information on both websites. The BDSC website provides a comprehensive list of tips for searches (https://bdsc.indiana.edu/search/search_tips.html) (accessed on 11 July 2024). As always, BDSC scientists are available to help users find any stocks. Users are encouraged to send feedback to BDSC (https://bdsc.indiana.edu/contact/index.html) (accessed on 11 July 2024). Questions and input help BDSC improve data dissemination and webpage construction.

Funding

The BDSC is supported by grant P40OD018537 from the NIH Office of Research Infrastructure Programs (ORIP) in collaboration with the National Institute of General Medical Sciences (NIGMS), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Child Health and Human Development (NICHD). The success of BDSC relies on a dedicated team of scientists, staff members, and stock keepers. The BDSC appreciates the unwavering support from the Drosophila community and valuable input from users. The author also wishes to acknowledge the tremendous contributions made by FlyBase to the Drosophila community.

Data Availability Statement

The data presented in this paper are query results of BDSC and FlyBase database. There are no archived datasets.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Mirisola, M.G.; Longo, V.D. Yeast Chronological Lifespan: Longevity Regulatory Genes and Mechanisms. Cells 2022, 11, 1714. [Google Scholar] [CrossRef] [PubMed]
  2. Lemoine, M. The Evolution of the Hallmarks of Aging. Front. Genet. 2021, 12, 693071. [Google Scholar] [CrossRef] [PubMed]
  3. Lin, C.J.; Neve, I.A.A.; Wang, M.C. Neuronal regulation of longevity by staying cool. Genes Dev. 2018, 32, 197–198. [Google Scholar] [CrossRef] [PubMed]
  4. Burtscher, J.; Soltany, A.; Visavadiya, N.P.; Burtscher, M.; Millet, G.P.; Khoramipour, K.; Khamoui, A.V. Mitochondrial stress and mitokines in aging. Aging Cell 2023, 22, e13770. [Google Scholar] [CrossRef]
  5. Dinić, M.; Herholz, M.; Kačarević, U.; Radojević, D.; Novović, K.; Đokić, J.; Trifunović, A.; Golić, N. Host-commensal interaction promotes health and lifespan in Caenorhabditis elegans through the activation of HLH-30/TFEB-mediated autophagy. Aging 2021, 13, 8040–8054. [Google Scholar] [CrossRef]
  6. Grenier, T.; Leulier, F. How commensal microbes shape the physiology of Drosophila melanogaster. Curr. Opin. Insect Sci. 2020, 41, 92–99. [Google Scholar] [CrossRef]
  7. Zavala, D.V.; Dzikowski, N.; Gopalan, S.; Harrington, K.D.; Pasquini, G.; Mogle, J.; Reid, K.; Sliwinski, M.; Graham-Engeland, J.E.; Engeland, C.G.; et al. Epigenetic Age Acceleration and Chronological Age: Associations With Cognitive Performance in Daily Life. J. Gerontol. Ser. A 2024, 79, glad242. [Google Scholar] [CrossRef]
  8. Bell, C.G.; Lowe, R.; Adams, P.D.; Baccarelli, A.A.; Beck, S.; Bell, J.T.; Christensen, B.C.; Gladyshev, V.N.; Heijmans, B.T.; Horvath, S.; et al. DNA methylation aging clocks: Challenges and recommendations. Genome Biol. 2019, 20, 249. [Google Scholar] [CrossRef]
  9. Kenyon, C.J. The genetics of ageing. Nature 2010, 464, 504–512. [Google Scholar] [CrossRef]
  10. Smulders, L.; Deelen, J. Genetics of human longevity: From variants to genes to pathways. J. Intern. Med. 2024, 295, 416–435. [Google Scholar] [CrossRef]
  11. Kenyon, C. A conserved regulatory system for aging. Cell 2001, 105, 165–168. [Google Scholar] [CrossRef] [PubMed]
  12. Min, K.J.; Tatar, M. Unraveling the Molecular Mechanism of Immunosenescence in Drosophila. Int. J. Mol. Sci. 2018, 19, 2472. [Google Scholar] [CrossRef] [PubMed]
  13. Fabrizio, P.; Pozza, F.; Pletcher, S.D.; Gendron, C.M.; Longo, V.D. Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001, 292, 288–290. [Google Scholar] [CrossRef] [PubMed]
  14. Kenyon, C.; Chang, J.; Gensch, E.; Rudner, A.; Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366, 461–464. [Google Scholar] [CrossRef] [PubMed]
  15. Tatar, M.; Kopelman, A.; Epstein, D.; Tu, M.P.; Yin, C.M.; Garofalo, R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 2001, 292, 107–110. [Google Scholar] [CrossRef]
  16. Clancy, D.J.; Gems, D.; Harshman, L.G.; Oldham, S.; Stocker, H.; Hafen, E.; Leevers, S.J.; Partridge, L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001, 292, 104–106. [Google Scholar] [CrossRef]
  17. Nelson, J.F.; Strong, R.; Bokov, A.; Diaz, V.; Ward, W. Probing the Relationship Between Insulin Sensitivity and Longevity Using Genetically Modified Mice. J. Gerontol. Ser. A 2012, 67, 1332–1338. [Google Scholar] [CrossRef]
  18. Cao, G.; Lin, M.; Gu, W.; Su, Z.; Duan, Y.; Song, W.; Liu, H.; Zhang, F. The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts. Life Sci. 2023, 328, 121877. [Google Scholar] [CrossRef]
  19. Curtis, R.; O’Connor, G.; DiStefano, P.S. Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 2006, 5, 119–126. [Google Scholar] [CrossRef]
  20. Martins, R.; Lithgow, G.J.; Link, W. Long live FOXO: Unraveling the role of FOXO proteins in aging and longevity. Aging Cell 2016, 15, 196–207. [Google Scholar] [CrossRef]
  21. Lin, K.; Dorman, J.B.; Rodan, A.; Kenyon, C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997, 278, 1319–1322. [Google Scholar] [CrossRef] [PubMed]
  22. Giannakou, M.E.; Goss, M.; Jünger, M.A.; Hafen, E.; Leevers, S.J.; Partridge, L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 2004, 305, 361. [Google Scholar] [CrossRef]
  23. Clancy, D.J.; Gems, D.; Hafen, E.; Leevers, S.J.; Partridge, L. Dietary restriction in long-lived dwarf flies. Science 2002, 296, 319. [Google Scholar] [CrossRef] [PubMed]
  24. Loo, J.; Shah Bana, M.A.F.; Tan, J.K.; Goon, J.A. Effect of dietary restriction on health span in Caenorhabditis elegans: A systematic review. Exp. Gerontol. 2023, 182, 112294. [Google Scholar] [CrossRef] [PubMed]
  25. Hahm, J.H.; Seo, H.D.; Jung, C.H.; Ahn, J. Longevity through diet restriction and immunity. BMB Rep. 2023, 56, 537–544. [Google Scholar] [CrossRef] [PubMed]
  26. Grande de França, N.A.; Rolland, Y.; Guyonnet, S.; de Souto Barreto, P. The role of dietary strategies in the modulation of hallmarks of aging. Ageing Res. Rev. 2023, 87, 101908. [Google Scholar] [CrossRef] [PubMed]
  27. Greer, E.L.; Dowlatshahi, D.; Banko, M.R.; Villen, J.; Hoang, K.; Blanchard, D.; Gygi, S.P.; Brunet, A. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 2007, 17, 1646–1656. [Google Scholar] [CrossRef] [PubMed]
  28. Novelle, M.G.; Ali, A.; Diéguez, C.; Bernier, M.; de Cabo, R. Metformin: A Hopeful Promise in Aging Research. Cold Spring Harb. Perspect. Med. 2016, 6, a025932. [Google Scholar] [CrossRef] [PubMed]
  29. Kulkarni, A.S.; Gubbi, S.; Barzilai, N. Benefits of Metformin in Attenuating the Hallmarks of Aging. Cell Metab. 2020, 32, 15–30. [Google Scholar] [CrossRef]
  30. Lee, D.J.W.; Hodzic Kuerec, A.; Maier, A.B. Targeting ageing with rapamycin and its derivatives in humans: A systematic review. Lancet Healthy Longev. 2024, 5, e152–e162. [Google Scholar] [CrossRef]
  31. Yang, F.; Liu, X.; Li, Y.; Yu, Z.; Huang, X.; Yang, G.; Xu, S. Evolutionary analysis of the mTOR pathway provide insights into lifespan extension across mammals. BMC Genom. 2023, 24, 456. [Google Scholar] [CrossRef] [PubMed]
  32. Cornu, M.; Albert, V.; Hall, M.N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 2013, 23, 53–62. [Google Scholar] [CrossRef] [PubMed]
  33. Bartke, A.; List, E.O.; Kopchick, J.J. The somatotropic axis and aging: Benefits of endocrine defects. Growth Horm. IGF Res. 2016, 27, 41–45. [Google Scholar] [CrossRef] [PubMed]
  34. Poloz, Y.; Stambolic, V. Obesity and cancer, a case for insulin signaling. Cell Death Dis. 2015, 6, e2037. [Google Scholar] [CrossRef] [PubMed]
  35. Bjedov, I.; Rallis, C. The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation. Genes 2020, 11, 1043. [Google Scholar] [CrossRef] [PubMed]
  36. Sun-Wang, J.L.; Ivanova, S.; Zorzano, A. The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing. Ageing Res. Rev. 2020, 64, 101203. [Google Scholar] [CrossRef] [PubMed]
  37. Watanabe, Y.; Taguchi, K.; Tanaka, M. Ubiquitin, Autophagy and Neurodegenerative Diseases. Cells 2020, 9, 2022. [Google Scholar] [CrossRef]
  38. Sharp, Z.D.; Strong, R. Rapamycin, the only drug that has been consistently demonstrated to increase mammalian longevity. An update. Exp. Gerontol. 2023, 176, 112166. [Google Scholar] [CrossRef]
  39. Maruzs, T.; Simon-Vecsei, Z.; Kiss, V.; Csizmadia, T.; Juhász, G. On the Fly: Recent Progress on Autophagy and Aging in Drosophila. Front. Cell Dev. Biol. 2019, 7, 140. [Google Scholar] [CrossRef]
  40. Zorov, D.B.; Juhaszova, M.; Sollott, S.J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 2014, 94, 909–950. [Google Scholar] [CrossRef]
  41. Picca, A.; Mankowski, R.T.; Burman, J.L.; Donisi, L.; Kim, J.-S.; Marzetti, E.; Leeuwenburgh, C. Mitochondrial quality control mechanisms as molecular targets in cardiac ageing. Nat. Rev. Cardiol. 2018, 15, 543–554. [Google Scholar] [CrossRef] [PubMed]
  42. Guo, Y.; Guan, T.; Shafiq, K.; Yu, Q.; Jiao, X.; Na, D.; Li, M.; Zhang, G.; Kong, J. Mitochondrial dysfunction in aging. Ageing Res. Rev. 2023, 88, 101955. [Google Scholar] [CrossRef] [PubMed]
  43. Maldonado, E.; Morales-Pison, S.; Urbina, F.; Solari, A. Aging Hallmarks and the Role of Oxidative Stress. Antioxidants 2023, 12, 651. [Google Scholar] [CrossRef] [PubMed]
  44. Picca, A.; Faitg, J.; Auwerx, J.; Ferrucci, L.; D’Amico, D. Mitophagy in human health, ageing and disease. Nat. Metab. 2023, 5, 2047–2061. [Google Scholar] [CrossRef] [PubMed]
  45. Giorgi, C.; Marchi, S.; Simoes, I.C.M.; Ren, Z.; Morciano, G.; Perrone, M.; Patalas-Krawczyk, P.; Borchard, S.; Jędrak, P.; Pierzynowska, K.; et al. Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases. Int. Rev. Cell Mol. Biol. 2018, 340, 209–344. [Google Scholar] [CrossRef] [PubMed]
  46. Weir, H.J.; Yao, P.; Huynh, F.K.; Escoubas, C.C.; Goncalves, R.L.; Burkewitz, K.; Laboy, R.; Hirschey, M.D.; Mair, W.B. Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab. 2017, 26, 884–896.e5. [Google Scholar] [CrossRef]
  47. Weichhart, T. mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review. Gerontology 2018, 64, 127–134. [Google Scholar] [CrossRef] [PubMed]
  48. Trefts, E.; Shaw, R.J. AMPK: Restoring metabolic homeostasis over space and time. Mol. Cell 2021, 81, 3677–3690. [Google Scholar] [CrossRef]
  49. Ryu, D.; Mouchiroud, L.; Andreux, P.A.; Katsyuba, E.; Moullan, N.; Nicolet-Dit-Félix, A.A.; Williams, E.G.; Jha, P.; Lo Sasso, G.; Huzard, D.; et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 2016, 22, 879–888. [Google Scholar] [CrossRef]
  50. Chamoli, M.; Rane, A.; Foulger, A.; Chinta, S.J.; Shahmirzadi, A.A.; Kumsta, C.; Nambiar, D.K.; Hall, D.; Holcom, A.; Angeli, S.; et al. A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan. Nat. Aging 2023, 3, 1529–1543. [Google Scholar] [CrossRef]
  51. Guo, J.; Chiang, W.C. Mitophagy in aging and longevity. IUBMB Life 2022, 74, 296–316. [Google Scholar] [CrossRef] [PubMed]
  52. Müller, L.; Fülöp, T.; Pawelec, G. Immunosenescence in vertebrates and invertebrates. Immun. Ageing 2013, 10, 12. [Google Scholar] [CrossRef] [PubMed]
  53. Pradeu, T.; Thomma, B.; Girardin, S.E.; Lemaitre, B. The conceptual foundations of innate immunity: Taking stock 30 years later. Immunity 2024, 57, 613–631. [Google Scholar] [CrossRef] [PubMed]
  54. Sciambra, N.; Chtarbanova, S. The Impact of Age on Response to Infection in Drosophila. Microorganisms 2021, 9, 958. [Google Scholar] [CrossRef] [PubMed]
  55. Santoro, A.; Bientinesi, E.; Monti, D. Immunosenescence and inflammaging in the aging process: Age-related diseases or longevity? Ageing Res. Rev. 2021, 71, 101422. [Google Scholar] [CrossRef] [PubMed]
  56. Garschall, K.; Flatt, T. The interplay between immunity and aging in Drosophila. F1000Res 2018, 7, 160. [Google Scholar] [CrossRef]
  57. Franceschi, C.; Bonafè, M.; Valensin, S.; Olivieri, F.; De Luca, M.; Ottaviani, E.; De Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908, 244–254. [Google Scholar] [CrossRef] [PubMed]
  58. Kaeberlein, M. How healthy is the healthspan concept? Geroscience 2018, 40, 361–364. [Google Scholar] [CrossRef] [PubMed]
  59. Wang, Y.; Qu, Z.; Chu, J.; Hun, S. Aging Gut Microbiome in Healthy and Unhealthy Aging. Aging Dis. 2024; online ahead of print. [Google Scholar] [CrossRef]
  60. Pereira, Q.C.; Fortunato, I.M.; Oliveira, F.S.; Alvarez, M.C.; Santos, T.W.D.; Ribeiro, M.L. Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging. Nutrients 2024, 16, 1066. [Google Scholar] [CrossRef]
  61. Loh, J.S.; Mak, W.Q.; Tan, L.K.S.; Ng, C.X.; Chan, H.H.; Yeow, S.H.; Foo, J.B.; Ong, Y.S.; How, C.W.; Khaw, K.Y. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct. Target. Ther. 2024, 9, 37. [Google Scholar] [CrossRef] [PubMed]
  62. Awe, T.; Fasawe, A.; Sawe, C.; Ogunware, A.; Jamiu, A.T.; Allen, M. The modulatory role of gut microbiota on host behavior: Exploring the interaction between the brain-gut axis and the neuroendocrine system. AIMS Neurosci. 2024, 11, 49–62. [Google Scholar] [CrossRef] [PubMed]
  63. Tan, F.H.P.; Shamsuddin, S.; Zainuddin, A. Ageing and the gut-brain axis: Lessons from the Drosophila model. Benef. Microbes 2023, 14, 591–607. [Google Scholar] [CrossRef] [PubMed]
  64. Wang, B.; Tang, X.; Mao, B.; Zhang, Q.; Tian, F.; Zhao, J.; Cui, S.; Chen, W. Anti-aging effects and mechanisms of anthocyanins and their intestinal microflora metabolites. Crit. Rev. Food Sci. Nutr. 2024, 64, 2358–2374. [Google Scholar] [CrossRef] [PubMed]
  65. Mattis, J.; Sehgal, A. Circadian Rhythms, Sleep, and Disorders of Aging. Trends Endocrinol. Metab. 2016, 27, 192–203. [Google Scholar] [CrossRef] [PubMed]
  66. Allada, R.; Bass, J. Circadian Mechanisms in Medicine. N. Engl. J. Med. 2021, 384, 550–561. [Google Scholar] [CrossRef] [PubMed]
  67. Rijo-Ferreira, F.; Takahashi, J.S. Genomics of circadian rhythms in health and disease. Genome Med. 2019, 11, 82. [Google Scholar] [CrossRef] [PubMed]
  68. Katewa, S.D.; Akagi, K.; Bose, N.; Rakshit, K.; Camarella, T.; Zheng, X.; Hall, D.; Davis, S.; Nelson, C.S.; Brem, R.B.; et al. Peripheral Circadian Clocks Mediate Dietary Restriction-Dependent Changes in Lifespan and Fat Metabolism in Drosophila. Cell Metab. 2016, 23, 143–154. [Google Scholar] [CrossRef]
  69. Lavallee, C.M.; Bruno, A.; Ma, C.; Raman, M. The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review. Nutrients 2022, 14, 4655. [Google Scholar] [CrossRef]
  70. Hu, X.; Peng, J.; Tang, W.; Xia, Y.; Song, P. A circadian rhythm-restricted diet regulates autophagy to improve cognitive function and prolong lifespan. Biosci. Trends 2023, 17, 356–368. [Google Scholar] [CrossRef]
  71. Yin, Z.; Klionsky, D.J. Intermittent time-restricted feeding promotes longevity through circadian autophagy. Autophagy 2022, 18, 471–472. [Google Scholar] [CrossRef] [PubMed]
  72. Ulgherait, M.; Midoun, A.M.; Park, S.J.; Gatto, J.A.; Tener, S.J.; Siewert, J.; Klickstein, N.; Canman, J.C.; Ja, W.W.; Shirasu-Hiza, M. Circadian autophagy drives iTRF-mediated longevity. Nature 2021, 598, 353–358. [Google Scholar] [CrossRef]
  73. Nathan, P.; Gibbs, J.E.; Rainger, G.E.; Chimen, M. Changes in Circadian Rhythms Dysregulate Inflammation in Ageing: Focus on Leukocyte Trafficking. Front. Immunol. 2021, 12, 673405. [Google Scholar] [CrossRef] [PubMed]
  74. Zhao, J.; Warman, G.R.; Cheeseman, J.F. The functional changes of the circadian system organization in aging. Ageing Res. Rev. 2019, 52, 64–71. [Google Scholar] [CrossRef] [PubMed]
  75. Froy, O. Circadian rhythms, aging, and life span in mammals. Physiology 2011, 26, 225–235. [Google Scholar] [CrossRef] [PubMed]
  76. Rabinovich-Nikitin, I.; Kirshenbaum, E.; Kirshenbaum, L.A. Autophagy, Clock Genes, and Cardiovascular Disease. Can. J. Cardiol. 2023, 39, 1772–1780. [Google Scholar] [CrossRef] [PubMed]
  77. McKee, C.A.; Polino, A.J.; King, M.W.; Musiek, E.S. Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes. Proc. Natl. Acad. Sci. USA 2023, 120, e2220551120. [Google Scholar] [CrossRef] [PubMed]
  78. Wang, X.; Xu, Z.; Cai, Y.; Zeng, S.; Peng, B.; Ren, X.; Yan, Y.; Gong, Z. Rheostatic Balance of Circadian Rhythm and Autophagy in Metabolism and Disease. Front. Cell Dev. Biol. 2020, 8, 616434. [Google Scholar] [CrossRef]
  79. Ryzhikov, M.; Ehlers, A.; Steinberg, D.; Xie, W.; Oberlander, E.; Brown, S.; Gilmore, P.E.; Townsend, R.R.; Lane, W.S.; Dolinay, T.; et al. Diurnal Rhythms Spatially and Temporally Organize Autophagy. Cell Rep. 2019, 26, 1880–1892.e6. [Google Scholar] [CrossRef]
  80. Kalfalah, F.; Janke, L.; Schiavi, A.; Tigges, J.; Ix, A.; Ventura, N.; Boege, F.; Reinke, H. Crosstalk of clock gene expression and autophagy in aging. Aging 2016, 8, 1876–1895. [Google Scholar] [CrossRef]
  81. Mauri, S.; Favaro, M.; Bernardo, G.; Mazzotta, G.M.; Ziviani, E. Mitochondrial autophagy in the sleeping brain. Front. Cell Dev. Biol. 2022, 10, 956394. [Google Scholar] [CrossRef]
  82. Bedont, J.L.; Toda, H.; Shi, M.; Park, C.H.; Quake, C.; Stein, C.; Kolesnik, A.; Sehgal, A. Short and long sleeping mutants reveal links between sleep and macroautophagy. eLife 2021, 10, e64140. [Google Scholar] [CrossRef]
  83. Mejía, S.T.; Su, T.T.; Washington, F.C.; Golinski, S.; Sosnoff, J.J. Everyday Experiences of Physical Function and Awareness of Fall Risk in Older Adulthood. Innov. Aging 2023, 7, igad037. [Google Scholar] [CrossRef]
  84. Atella, V.; Piano Mortari, A.; Kopinska, J.; Belotti, F.; Lapi, F.; Cricelli, C.; Fontana, L. Trends in age-related disease burden and healthcare utilization. Aging Cell 2019, 18, e12861. [Google Scholar] [CrossRef] [PubMed]
  85. Kim, C.K.; Lee, Y.R.; Ong, L.; Gold, M.; Kalali, A.; Sarkar, J. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures. J. Alzheimers Dis. 2022, 87, 83–100. [Google Scholar] [CrossRef]
  86. Liu, W.S.; You, J.; Ge, Y.J.; Wu, B.S.; Zhang, Y.; Chen, S.D.; Zhang, Y.R.; Huang, S.Y.; Ma, L.Z.; Feng, J.F.; et al. Association of biological age with health outcomes and its modifiable factors. Aging Cell 2023, 22, e13995. [Google Scholar] [CrossRef] [PubMed]
  87. Moskalev, A.; Guvatova, Z.; Lopes, I.A.; Beckett, C.W.; Kennedy, B.K.; De Magalhaes, J.P.; Makarov, A.A. Targeting aging mechanisms: Pharmacological perspectives. Trends Endocrinol. Metab. 2022, 33, 266–280. [Google Scholar] [CrossRef] [PubMed]
  88. Bakula, D.; Ablasser, A.; Aguzzi, A.; Antebi, A.; Barzilai, N.; Bittner, M.I.; Jensen, M.B.; Calkhoven, C.F.; Chen, D.; Grey, A.; et al. Latest advances in aging research and drug discovery. Aging 2019, 11, 9971–9981. [Google Scholar] [CrossRef]
  89. Meron, E.; Thaysen, M.; Angeli, S.; Antebi, A.; Barzilai, N.; Baur, J.A.; Bekker-Jensen, S.; Birkisdottir, M.; Bischof, E.; Bruening, J.; et al. Meeting Report: Aging Research and Drug Discovery. Aging 2022, 14, 530–543. [Google Scholar] [CrossRef]
  90. Kennedy, B.K.; Pennypacker, J.K. Drugs that modulate aging: The promising yet difficult path ahead. Transl. Res. 2014, 163, 456–465. [Google Scholar] [CrossRef]
  91. Ogienko, A.A.; Omelina, E.S.; Bylino, O.V.; Batin, M.A.; Georgiev, P.G.; Pindyurin, A.V. Drosophila as a Model Organism to Study Basic Mechanisms of Longevity. Int. J. Mol. Sci. 2022, 23, 11244. [Google Scholar] [CrossRef] [PubMed]
  92. Nainu, F.; Bahar, M.A.; Sartini, S.; Rosa, R.A.; Rahmah, N.; Kamri, R.A.; Rumata, N.R.; Yulianty, R.; Wahyudin, E. Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators. Sci. Pharm. 2022, 90, 11. [Google Scholar] [CrossRef]
  93. Gasque, G.; Conway, S.; Huang, J.; Rao, Y.; Vosshall, L.B. Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target. Sci. Rep. 2013, 3, srep02120. [Google Scholar] [CrossRef]
  94. Munnik, C.; Xaba, M.P.; Malindisa, S.T.; Russell, B.L.; Sooklal, S.A. Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies. Front. Genet. 2022, 13, 949241. [Google Scholar] [CrossRef] [PubMed]
  95. Su, T.T. Drug screening in Drosophila; why, when, and when not? Wiley Interdiscip. Rev. Dev. Biol. 2019, 8, e346. [Google Scholar] [CrossRef] [PubMed]
  96. Hussain, R.; Lim, C.X.; Shaukat, Z.; Islam, A.; Caseley, E.A.; Lippiat, J.D.; Rychkov, G.Y.; Ricos, M.G.; Dibbens, L.M. Drosophila expressing mutant human KCNT1 transgenes make an effective tool for targeted drug screening in a whole animal model of KCNT1-epilepsy. Sci. Rep. 2024, 14, 3357. [Google Scholar] [CrossRef]
  97. DeLoriea, J.; Millet-Boureima, C.; Gamberi, C. Protocol to build a drug-testing pipeline using large populations of Drosophila melanogaster. STAR Protoc. 2023, 4, 102747. [Google Scholar] [CrossRef] [PubMed]
  98. Hohman, L.S.; Osborne, L.C. A gut-centric view of aging: Do intestinal epithelial cells contribute to age-associated microbiota changes, inflammaging, and immunosenescence? Aging Cell 2022, 21, e13700. [Google Scholar] [CrossRef] [PubMed]
  99. Ni, J.Q.; Markstein, M.; Binari, R.; Pfeiffer, B.; Liu, L.P.; Villalta, C.; Booker, M.; Perkins, L.; Perrimon, N. Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nat. Methods 2008, 5, 49–51. [Google Scholar] [CrossRef]
  100. Öztürk-Çolak, A.; Marygold, S.J.; Antonazzo, G.; Attrill, H.; Goutte-Gattat, D.; Jenkins, V.K.; Matthews, B.B.; Millburn, G.; dos Santos, G.; Tabone, C.J.; et al. FlyBase: Updates to the Drosophila genes and genomes database. Genetics 2024, 227, iyad211. [Google Scholar] [CrossRef]
  101. Hu, Y.; Comjean, A.; Mohr, S.E.; Perrimon, N. Gene2Function: An Integrated Online Resource for Gene Function Discovery. G3 2017, 7, 2855–2858. [Google Scholar] [CrossRef] [PubMed]
  102. Hu, Y.; Chung, V.; Comjean, A.; Rodiger, J.; Nipun, F.; Perrimon, N.; Mohr, S.E. BioLitMine: Advanced Mining of Biomedical and Biological Literature About Human Genes and Genes from Major Model Organisms. G3 2020, 10, 4531–4539. [Google Scholar] [CrossRef] [PubMed]
  103. Jenkins, V.K.; Larkin, A.; Thurmond, J. Using FlyBase: A Database of Drosophila Genes and Genetics. In Drosophila: Methods and Protocols; Dahmann, C., Ed.; Springer: New York, NY, USA, 2022; pp. 1–34. [Google Scholar]
  104. Zhang, H. The Genetics of Autophagy in Multicellular Organisms. Annu. Rev. Genet. 2022, 56, 17–39. [Google Scholar] [CrossRef] [PubMed]
  105. Juhász, G.; Erdi, B.; Sass, M.; Neufeld, T.P. Atg7-dependent autophagy promotes neuronal health, stress tolerance, and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev. 2007, 21, 3061–3066. [Google Scholar] [CrossRef] [PubMed]
  106. Simonsen, A.; Cumming, R.C.; Brech, A.; Isakson, P.; Schubert, D.R.; Finley, K.D. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008, 4, 176–184. [Google Scholar] [CrossRef] [PubMed]
  107. Ulgherait, M.; Rana, A.; Rera, M.; Graniel, J.; Walker, D.W. AMPK modulates tissue and organismal aging in a non-cell-autonomous manner. Cell Rep. 2014, 8, 1767–1780. [Google Scholar] [CrossRef] [PubMed]
  108. Pyo, J.-O.; Yoo, S.-M.; Ahn, H.-H.; Nah, J.; Hong, S.-H.; Kam, T.-I.; Jung, S.; Jung, Y.-K. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 2013, 4, 2300. [Google Scholar] [CrossRef] [PubMed]
  109. Shaukat, Z.; Liu, D.; Gregory, S. Sterile inflammation in Drosophila. Mediat. Inflamm. 2015, 2015, 369286. [Google Scholar] [CrossRef]
  110. Arch, M.; Vidal, M.; Koiffman, R.; Melkie, S.T.; Cardona, P.-J. Drosophila melanogaster as a model to study innate immune memory. Front. Microbiol. 2022, 13, 991678. [Google Scholar] [CrossRef]
  111. García-García, V.A.; Alameda, J.P.; Page, A.; Casanova, M.L. Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models. Cells 2021, 10, 1906. [Google Scholar] [CrossRef]
  112. Kounatidis, I.; Chtarbanova, S. Role of Glial Immunity in Lifespan Determination: A Drosophila Perspective. Front. Immunol. 2018, 9, 1362. [Google Scholar] [CrossRef] [PubMed]
  113. Khor, S.; Cai, D. Control of lifespan and survival by Drosophila NF-κB signaling through neuroendocrine cells and neuroblasts. Aging 2020, 12, 24604–24622. [Google Scholar] [CrossRef] [PubMed]
  114. Ehrenreich, I.M.; Torabi, N.; Jia, Y.; Kent, J.; Martis, S.; Shapiro, J.A.; Gresham, D.; Caudy, A.A.; Kruglyak, L. Dissection of genetically complex traits with extremely large pools of yeast segregants. Nature 2010, 464, 1039–1042. [Google Scholar] [CrossRef] [PubMed]
  115. King, E.G.; Merkes, C.M.; McNeil, C.L.; Hoofer, S.R.; Sen, S.; Broman, K.W.; Long, A.D.; Macdonald, S.J. Genetic dissection of a model complex trait using the Drosophila Synthetic Population Resource. Genome Res. 2012, 22, 1558–1566. [Google Scholar] [CrossRef] [PubMed]
  116. Macdonald, S.J.; Long, A.D. Discovery of malathion resistance QTL in Drosophila melanogaster using a bulked phenotyping approach. G3 Genes|Genomes|Genet. 2022, 12, jkac279. [Google Scholar] [CrossRef] [PubMed]
  117. Mackay, T.F.; Richards, S.; Stone, E.A.; Barbadilla, A.; Ayroles, J.F.; Zhu, D.; Casillas, S.; Han, Y.; Magwire, M.M.; Cridland, J.M.; et al. The Drosophila melanogaster Genetic Reference Panel. Nature 2012, 482, 173–178. [Google Scholar] [CrossRef] [PubMed]
  118. Ariyapala, I.S.; Holsopple, J.M.; Popodi, E.M.; Hartwick, D.G.; Kahsai, L.; Cook, K.R.; Sokol, N.S. Identification of Split-GAL4 Drivers and Enhancers That Allow Regional Cell Type Manipulations of the Drosophila melanogaster Intestine. Genetics 2020, 216, 891–903. [Google Scholar] [CrossRef] [PubMed]
  119. Newby, L.M.; Jackson, F.R. Drosophila ebony mutants have altered circadian activity rhythms but normal eclosion rhythms. J. Neurogenet. 1991, 7, 85–101. [Google Scholar] [CrossRef] [PubMed]
  120. He, Y.; Jasper, H. Studying aging in Drosophila. Methods 2014, 68, 129–133. [Google Scholar] [CrossRef]
  121. Martin, I.; Grotewiel, M.S. Distinct genetic influences on locomotor senescence in Drosophila revealed by a series of metrical analyses. Exp. Gerontol. 2006, 41, 877–881. [Google Scholar] [CrossRef]
Figure 1. BDSC website homepage layout. The BDSC website (https://bdsc.indiana.edu/) accessed on 11 July 2024) is accessible via any of the major internet browsers on desktop and mobile devices. The “More…” link opens a new page with most pre-compiled stock categories.
Figure 1. BDSC website homepage layout. The BDSC website (https://bdsc.indiana.edu/) accessed on 11 July 2024) is accessible via any of the major internet browsers on desktop and mobile devices. The “More…” link opens a new page with most pre-compiled stock categories.
Cells 13 01192 g001
Figure 2. Illustration of the Advanced Stock Search. Clicking on the top toggle of “any/or” changes the query design accordingly, i.e., the Operator “or” is used for “any”, and the Operator “and” is used for “all”. The gray boxes contain a dropdown list that is shown by clicking on the triangle.
Figure 2. Illustration of the Advanced Stock Search. Clicking on the top toggle of “any/or” changes the query design accordingly, i.e., the Operator “or” is used for “any”, and the Operator “and” is used for “all”. The gray boxes contain a dropdown list that is shown by clicking on the triangle.
Cells 13 01192 g002
Figure 3. Illustration of the Advanced Symbol Search. Clicking on the top toggle of “any/or” changes the query design accordingly, i.e., the Operator “or” is used for “any”, and the Operator “and” is used for “all”. The gray boxes contain a dropdown list that is shown by clicking on the triangle. Category terms are further explained in Table 1.
Figure 3. Illustration of the Advanced Symbol Search. Clicking on the top toggle of “any/or” changes the query design accordingly, i.e., the Operator “or” is used for “any”, and the Operator “and” is used for “all”. The gray boxes contain a dropdown list that is shown by clicking on the triangle. Category terms are further explained in Table 1.
Cells 13 01192 g003
Figure 4. Flow chart for using BDSC or FlyBase to find stocks. Use BDSC for stock numbers since it has the most current information about genotype and stock availability. Use FlyBase for reference, gene ontology, and pathway searches. Symbols (gene, component) on the BDSC webpage are linked to FlyBase, which provides vast genetic and molecular data, linkouts, and references for further reading.
Figure 4. Flow chart for using BDSC or FlyBase to find stocks. Use BDSC for stock numbers since it has the most current information about genotype and stock availability. Use FlyBase for reference, gene ontology, and pathway searches. Symbols (gene, component) on the BDSC webpage are linked to FlyBase, which provides vast genetic and molecular data, linkouts, and references for further reading.
Cells 13 01192 g004
Figure 5. Using a FlyBase Pathways search to find stocks. (1). On the FlyBase homepage (https://flybase.org/) (accessed on 11 July 2024), select “Pathways” and enter “insulin” in the search box, then select “insulin-like Receptor Signaling Pathway” from the dropdown. (2). Click on the gene group link (FBgg0000910) to open the Gene group report page. (3). In the “Members” section, click on the “Export to HitList” to fetch alleles and stocks. (4). Select “Stocks” from the dropdown menu. (5). Select “Collection” and then “Bloomington Drosophila Stock Center” in the popup window. (6). Select “Batch Download” to export the list (stock number, genotype). Note that the numbers in this illustration and other sections are based on FB2024_03, released 25 June 2024.
Figure 5. Using a FlyBase Pathways search to find stocks. (1). On the FlyBase homepage (https://flybase.org/) (accessed on 11 July 2024), select “Pathways” and enter “insulin” in the search box, then select “insulin-like Receptor Signaling Pathway” from the dropdown. (2). Click on the gene group link (FBgg0000910) to open the Gene group report page. (3). In the “Members” section, click on the “Export to HitList” to fetch alleles and stocks. (4). Select “Stocks” from the dropdown menu. (5). Select “Collection” and then “Bloomington Drosophila Stock Center” in the popup window. (6). Select “Batch Download” to export the list (stock number, genotype). Note that the numbers in this illustration and other sections are based on FB2024_03, released 25 June 2024.
Cells 13 01192 g005
Table 1. Dropdown menu description of gene–component symbol associations.
Table 1. Dropdown menu description of gene–component symbol associations.
Dropdown ItemDescription
all categoriesNo filter for any category
alleleClassical gene alleles, insertions associated with altered genomic DNA
antibody fragment againstGene product targeted by antibody expressed from the transgene
codingInsertions carrying coding sequence for the gene
coding and regulatoryInsertions carrying both coding and regulatory sequences for the gene
deficiency or putative deficiencyDeficiencies that delete or may delete the gene
gene trapInsertion sequences may be transcribed with the gene
guideRNAGuide RNAs for the gene
inserted or swapped inInsertions in the gene
noncoding RNAInsertions carrying a noncoding RNA gene
potential misexpressionInsertions carrying UAS sequences that might direct expression of nearby genes
protein binding site (e.g., FRT or loxP site)Transgenes harboring non-regulatory DNA sequences (e.g., recombinase target sites)
protein trapInsertion sequences (usually reporter) may be incorporated into the protein
regulatory or putative regulatoryInsertions carrying regulatory or putative regulatory sequences from the gene
RNA spongeInsertions carrying RNA for sequestering the gene transcript
RNAiInsertions carrying sequences for RNAi against the gene
wildtype alleleWild-type alleles of the gene
Zn finger nucleaseInsertions carrying Zn finger nuclease that targets the gene
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zheng, X. An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research. Cells 2024, 13, 1192. https://doi.org/10.3390/cells13141192

AMA Style

Zheng X. An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research. Cells. 2024; 13(14):1192. https://doi.org/10.3390/cells13141192

Chicago/Turabian Style

Zheng, Xiangzhong. 2024. "An Introductory Guide to Using Bloomington Drosophila Stock Center and FlyBase for Aging Research" Cells 13, no. 14: 1192. https://doi.org/10.3390/cells13141192

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop